Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05224440Not ApplicableRecruiting

National Sponsorship Program for Transitioning Service Members

Role: collaborator

NCT03056157Not ApplicableCompleted

Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure

Role: collaborator

NCT03529435Not ApplicableCompleted

Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD

Role: collaborator

NCT00633685Phase 4Unknown

Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress Exposure

Role: collaborator

NCT00290316Phase 2Unknown

Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver

Role: lead

All 5 trials loaded